DOI: 10.12890/2025_005290

From presentation to prognosis: a challenging case of multifocal cerebral microabscesses due to Citrobacter freundii

Authors

  • Varsha Nandwana Department of Internal Medicine, Section of Neurology, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, USA
  • Liam M. Cleary Department of Internal Medicine, Section of Neurology, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, USA
  • Thomas V. Kodankandath Department of Internal Medicine, Section of Neurology, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, USA

vnandwana@carilionclinic.org

Keywords

Citrobacter freundii, brain abscess, central nervous system infections

Abstract

Introduction: Citrobacter freundii is a rare cause of central nervous system (CNS) infections, primarily affecting neonates. In adults, cases are uncommon and often associated with high mortality rates.
Case description: We describe the case of an adult male with multiple comorbidities who presented with constipation, nausea and vomiting, which rapidly progressed to altered mental status and seizures. Neuroimaging revealed gas densities within intracranial veins and evolving encephalitic changes. Cerebrospinal fluid (CSF) findings were non-specific, but blood and wound cultures identified C. freundii. Targeted antibiotic therapy with cefepime and ampicillin-sulbactam was initiated, but the patient’s condition deteriorated leading to withdrawal of care, and death. Autopsy confirmed multiple cerebral micro abscesses, consistent with septic embolization.
Conclusion: This case highlights C. freundii as a rare but fatal cause of septic encephalopathy. Diagnostic challenges arose from the atypical neurological presentation and non-specific CSF findings. The transition to cefepime was guided by concerns over C. freundii’s AmpC beta-lactamase production. Despite appropriate antimicrobial therapy, the patient’s poor outcome underscored the challenges of managing CNS infections in relatively immunocompromised hosts. Early recognition of C. freundii CNS infections is crucial, particularly in high-risk patients. A high index of suspicion, serial imaging and tailored antimicrobial therapy are essential for optimising outcomes. Further research is needed to enhance diagnostic methods and treatment strategies.

View the entire article

Downloads

References

  1. Lok-Ming T, Sien-Tsong C, Tai-Ngar L. Citrobacter meningitis in adults. Clin Neurol Neurosurg 1994;96:52–57. doi: 10.1016/0303-8467(94)90030-2
  2. Ozawa Y, Uzawa A, Kanai T, Oda F, Yasuda M, Kawaguchi N, et al. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis. J Neurol Sci 2019;402:12–15. doi: 10.1016/j.jns.2019.05.003
  3. Liu HW, Chang CJ, Hsieh CT. Brain abscess caused by Citrobacter koseri infection in an adult. Neurosciences (Riyadh) 2015;20:170–172. doi: 10.17712/nsj.2015.2.20140749
  4. Chen XB, Zhou YX, Feng Y. Citrobacter freundii induces sepsis with new-onset status seizure in an adult: a case report and literature review. Medicine (Baltimore) 2023;102:e32549. doi: 10.1097/MD.0000000000032549
  5. Tebano G, Zaghi I, Cricca M, Cristini F. Antibiotic treatment of infections caused by AmpC-producing enterobacterales. Pharmacy (Basel) 2024;12:142. doi: 10.3390/pharmacy12050142

Published

2025-05-29

How to Cite

1.
Nandwana V, Cleary LM, Kodankandath TV. From presentation to prognosis: a challenging case of multifocal cerebral microabscesses due to Citrobacter freundii. EJCRIM [Internet]. 2025 May 29 [cited 2026 Nov. 3];12(6). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5290